Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,716,144
-$383,055 QoQ
Shares Held
23,712
-11.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#317
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EagleClaw Capital Managment, LLC holds $45,392,435 across 12 Drug Manufacturers - General names. NVS ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
71,774 | $18,061,209 | |
| 2 | JNJ |
Johnson & Johnson
|
22,283 | $5,659,213 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,088 | $3,866,308 | |
| 4 | NVS |
Novartis AG
This page
|
23,712 | $3,716,144 | |
| 5 | PFE |
Pfizer Inc
|
153,401 | $3,693,896 | |
| 6 | NVO |
Novo Nordisk A S
|
63,650 | $3,051,381 | |
| 7 | LLY |
ELI LILLY & Co
|
1,772 | $2,125,390 | |
| 8 | SNY |
Sanofi
|
45,410 | $1,937,190 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,716,144 | 23,712 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,099,199 | 26,836 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,816,517 | 27,682 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,601,235 | 28,082 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,014,117 | 24,908 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,776,743 | 24,908 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,445,789 | 25,134 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,580,358 | 22,434 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,585,274 | 24,284 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,348,991 | 24,284 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,385,315 | 23,624 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,375,782 | 23,324 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,277,942 | 22,574 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,145,808 | 23,324 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $2,206,128 | 24,318 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,863,613 | 24,518 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,104,205 | 24,893 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,177,077 | 24,810 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,183,251 | 24,960 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,008,516 | 24,560 | Shares | Sole | 2021-12-02 | |
| 2021-06-30 | $2,181,548 | 23,910 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,879,277 | 21,985 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,076,043 | 21,985 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,911,815 | 21,985 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,843,747 | 21,110 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,818,847 | 22,060 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||